KABIDARA 25MCG INJECTION

Kabidara 25mcg Injection is a long-acting erythropoiesis-stimulating agent used to treat anemia associated with chronic kidney disease and chemotherapy. It contains Darbepoetin Alfa, which helps the bone marrow produce more red blood cells, improving hemoglobin levels and oxygen supply in the body. This injectable therapy is administered under medical supervision for safe and controlled anemia management.

Kabidara 25 mcg Injection offers extended activity compared to conventional erythropoietin, allowing less frequent dosing while maintaining stable hemoglobin levels. It is commonly recommended for dialysis and oncology patients experiencing fatigue, weakness, or breathlessness due to anemia. Regular monitoring ensures proper dosing and optimal therapeutic response.

Kabidara 25 mcg Injection ensures purity, safety, and consistent performance. It is widely supplied to hospitals, clinics, and international pharmaceutical buyers seeking reliable anemia care solutions.

Product Features

• Contains Darbepoetin Alfa 25mcg
• Long-acting erythropoiesis-stimulating agent
• Used for CKD and chemotherapy-related anemia
• Helps maintain stable hemoglobin levels
• High-quality sterile injectable formulation

How It Helps

• Boosts red blood cell production
• Reduces fatigue caused by anemia
• Improves oxygen delivery in the body
• Supports better energy and daily activity